Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multi-center and Multi-omics Mechanism Research of Gut Microbiota and Metabonomics in Borrmann Type IV Gastric Cancer

NCT05205187 is registered in ClinicalTrials.gov with First Hospital of China Medical University as lead sponsor.

NCT NCT05205187
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05205187 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multi-center and Multi-omics Mechanism Research of Gut Microbiota and Metabonomics in Borrmann Type IV Gastric Cancer
Lead sponsor
First Hospital of China Medical University
Phase
Observational
Overall status
Unknown status
Start date
February 28, 2022
Completion date
December 31, 2025
Enrollment
450 (estimated)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

gut microbiota, metabolomics, stomach neoplasms